FDA: Massachusetts compounding problem may be broader than steroid injection

“At this point in FDA’s investigation, the sterility of any injectable drugs … produced by [The New England Compounding Center] are of significant concern,” the agency wrote in a statement posted on its website, “and out of an abundance of caution, patients who received these products should be alerted to the potential risk of infection.”


Read more: [link to www.politico.com]